NGeneBio Co., Ltd. (KOSDAQ: 354200)
South Korea
· Delayed Price · Currency is KRW 2,250.00
-45.00 (-1.96%)
Dec 19, 2024, 9:00 AM KST
NGeneBio Revenue
NGeneBio had revenue of 2.07B KRW in the quarter ending September 30, 2024, with 132.70% growth. This brings the company's revenue in the last twelve months to 6.18B, up 37.56% year-over-year. In the year 2023, NGeneBio had annual revenue of 4.35B, down -60.51%.
Revenue (ttm)
6.18B
Revenue Growth
+37.56%
P/S Ratio
4.45
Revenue / Employee
88.23M
Employees
70
Market Cap
29.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.35B | -6.67B | -60.51% |
| Dec 31, 2022 | 11.02B | 3.85B | 53.81% |
| Dec 31, 2021 | 7.16B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition